NCT00555048 2017-05-24Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerFred Hutchinson Cancer CenterPhase 1/2 Terminated1 enrolled 5 charts
NCT00683046 2016-11-22T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesUniversity of ChicagoPhase 2 Completed204 enrolled 7 charts
NCT00818961 2013-12-18Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerNorthside Hospital, Inc.Phase 2 Terminated36 enrolled 16 charts